The European Medicines Agency has issued new advice on the procedures that companies should follow in developing stem cell products. The advice is contained in a paper on the agency’s website, www.ema.europa.eu. (EMA/CAT/571134/2009).
The European Medicines Agency has issued new advice on the procedures that companies should follow in developing stem cell products. The advice is contained in a paper on the agency’s website, www.ema.europa.eu. (EMA/CAT/571134/2009).